Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease
Ioulia Mavrikou(G. Papanikolaou General Hospital), Eleni Gavriilaki(Aristotle University of Thessaloniki), Christos Demosthenous(G. Papanikolaou General Hospital), Apostolia Papalexandri(G. Papanikolaou General Hospital), Emmanouil Nikolousis(Dubai Hospital), Evaggelia‐Evdoxia Koravou(G. Papanikolaou General Hospital), Maria Koutra(G. Papanikolaou General Hospital), Dimitrios Chatzidimitriou(Aristotle University of Thessaloniki), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Ioannis Batsis(G. Papanikolaou General Hospital), Daniela Taurino(IRCCS Humanitas Research Hospital), Anna Vardi(G. Papanikolaou General Hospital), Evangelia Yannaki(G. Papanikolaou General Hospital), Ioanna Sakellari(Aristotle University of Thessaloniki), Tasoula Touloumenidou(G. Papanikolaou General Hospital), Alkistis Panteliadou(G. Papanikolaou General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627